Article

Accommodating IOL available in quarter-diopter steps

The FDA has approved the marketing of an accommodating IOL (Crystalens AO, Bausch + Lomb) in quarter-diopter steps in the United States.

Aliso Viejo, CA

-The FDA has approved the marketing of an accommodating IOL (Crystalens AO, Bausch + Lomb) in quarter-diopter steps in the United States.

The company began shipping the lens in the additional diopter steps in mid-May.

The FDA first approved this implant in 2003, and it remains the only FDA-approved accommodating lens. The IOL, now in its fifth generation, also recently received new technology IOL (NTIOL) status from the Centers for Medicare and Medicaid Services.

Quarter-diopter steps are available for two models of the lens (AT50AO, AT52AO), in the ranges of 18 to 22 D. A wider dioptric range should be available by the end of the year, according to the company.

"Quarter-diopter steps for the Crystalens Five-0 and HD have been enthusiastically accepted by surgeons, so we have now added them to the AO model," said Tom Frinzi, vice president of global commercial operations, Bausch + Lomb Surgical. "We still remain the only presbyopic channel lenses available in the United States in quarter-diopter steps and the only presbyopic lens with NTIOL status."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23
(Image credit: Ophthalmology Times) Accelerating eye health innovation through CCOI – Stanford Summit
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
© 2025 MJH Life Sciences

All rights reserved.